AAA specialist Endologix raises $16.6m from private placement:
This article was originally published in Clinica
Endologix, the Irvine, California manufacturer of the minimally invasive Powerlink stent graft system to treat abdominal aortic aneurysms (AAAs), has agreed a private placement to raise $16.6m. It intends to invest the funds in a wider roll-out of Powerlink, which it has begun to commercialise in selected hospitals. It will hire new sales reps and expand the marketing programme.
You may also be interested in...
Steve Niedelman of the law firm King & Spalding gave manufacturers a few words of advice when prepping their so-called front rooms, where US FDA investigators do the majority of their work during facility inspections. See what he said here.
The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”